119 related articles for article (PubMed ID: 4659050)
21. Skin melanoma induced by 7,12-dimethylbenzanthracene in albino guinea pigs and its similarities to skin melanoma of humans.
Pawlowski A; Haberman HF; Menon IA
Cancer Res; 1980 Oct; 40(10):3652-60. PubMed ID: 6777035
[TBL] [Abstract][Full Text] [Related]
22. Immunological factors which influence response to immunotherapy in malignant melanoma.
Morton D; Eilber FR; Malmgren RA; Wood WC
Surgery; 1970 Jul; 68(1):158-63; discussion 163-4. PubMed ID: 10483463
[TBL] [Abstract][Full Text] [Related]
23. [Immunotherapy of cancer].
Gil Extremera B
Rev Clin Esp; 1976 Aug; 142(3):281-91. PubMed ID: 788067
[No Abstract] [Full Text] [Related]
24. Immunotherapy of sarcomas.
Leventhal BG
Natl Cancer Inst Monogr; 1981 Apr; (56):183-7. PubMed ID: 6170891
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy with viral oncolysates for sarcoma.
Sinkovics JG
JAMA; 1977 Feb; 237(9):869. PubMed ID: 319278
[No Abstract] [Full Text] [Related]
26. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
Boyle MD; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
28. Specific cytotoxic antibody in the sera of patients with melanoma.
Kilpatrick RJ; Seigler HF
J Surg Res; 1976 Nov; 21(5):301-5. PubMed ID: 794584
[No Abstract] [Full Text] [Related]
29. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
[TBL] [Abstract][Full Text] [Related]
30. Cancer topics: immunology and cancer revisited.
O'Brien PH
J S C Med Assoc; 1974 Jul; 70(7):223-6. PubMed ID: 4603086
[No Abstract] [Full Text] [Related]
31. Immunotherapeutic activity of percutaneous BCG vaccine: laboratory and clinical studies.
Engibarov A; Chouchkova M; Ikonopisov R
Dev Biol Stand; 1986; 58 ( Pt A)():365-9. PubMed ID: 3596042
[No Abstract] [Full Text] [Related]
32. [Antibody synthesis in immunocompetent organs in BCG vaccination in experiment].
Averbakh MM; Litvinov VI
Arkh Patol; 1968; 30(7):33-8. PubMed ID: 4882266
[No Abstract] [Full Text] [Related]
33. [Immunological aspects of malignant melanomas of the choroid].
Le Hoang P
Bull Soc Ophtalmol Fr; 1986 Nov; Spec No():143-51. PubMed ID: 3791545
[No Abstract] [Full Text] [Related]
34. Results of adjuvant BCG immunotherapy in malignant melanoma.
Wätzig V; Knopf B
Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442
[TBL] [Abstract][Full Text] [Related]
35. Clinical experiences in immunotherapy of cancer.
Krementz ET; Samuels MS; Wallace JH; Benes EN
Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
[No Abstract] [Full Text] [Related]
36. Immunotherapy and immune competence of patients with malignant melanoma.
Kovarík J; Ninger E; Mechl Z; Zemanová D; Lauerová L; Sopková B; Svejda J; Bacovský B; Bártová A; Bártek J
Czech Med; 1983; 6(3):172-4. PubMed ID: 6416794
[No Abstract] [Full Text] [Related]
37. Feasibility of integration of modalities in melanomas and sarcomas.
Karakousis CP; Lopez R; Berger JL; Takita H; Friedman M; Holyoke ED
Am J Surg; 1979 Mar; 137(3):369-73. PubMed ID: 434333
[TBL] [Abstract][Full Text] [Related]
38. Preliminary results of nonspecific immunotherapy for lung cancer.
Israel L
Cancer Chemother Rep 3; 1973 Mar; 4(2):283-6. PubMed ID: 4729331
[No Abstract] [Full Text] [Related]
39. Immunology and the melanomas.
Lewis MG
Curr Top Microbiol Immunol; 1974; 63():49-84. PubMed ID: 4597749
[No Abstract] [Full Text] [Related]
40. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
Baldwin RW; Pimm MV
Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
